| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/22/2010 | WO2009117289A3 Methods for treating psoriasis |
| 04/22/2010 | WO2009114485A3 Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
| 04/22/2010 | WO2009112670A3 Use of a protein or nitrated peptide sequence for implementing a diagnosis method |
| 04/22/2010 | US20100100979 Biomarker specific for cancer |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100099854 Neurovirulent strain of the west nile virus and uses thereof |
| 04/22/2010 | US20100099853 Multivalent Antibody Constructs |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100099201 Methods and compositions relating to isocyanate conjugates |
| 04/22/2010 | US20100099184 Polynucleotides encoding class ii cytokine receptor-7 |
| 04/22/2010 | US20100099168 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex |
| 04/22/2010 | US20100099147 Anti-IGF-1R Antibodies and Uses Thereof |
| 04/22/2010 | US20100099122 Ferric reductase activity of histoplasma capsulatum y-glutamyltransferase |
| 04/22/2010 | US20100099111 Antibodies against a protein entitled 161p2f10b |
| 04/22/2010 | US20100099105 Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (bcrp) |
| 04/22/2010 | US20100098730 Immunoglobulin variants and uses thereof |
| 04/22/2010 | US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis |
| 04/22/2010 | US20100098723 Vaccine compositions against infectious pathologies for mammals |
| 04/22/2010 | US20100098719 Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G |
| 04/22/2010 | US20100098718 Nucleic acid vectors for immunization |
| 04/22/2010 | US20100098717 Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor |
| 04/22/2010 | US20100098707 amyloidosis; neurological disorders such as Alzheimer's Disease |
| 04/22/2010 | US20100098706 Monoclonal antibody directed against the human ldl receptor |
| 04/22/2010 | US20100098704 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 04/22/2010 | US20100098703 Determination of am-binding proteins and the association of adrenomedullin (am) therewith |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098696 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 04/22/2010 | US20100098695 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | US20100098693 Compositions and methods for blood-brain barrier delivery of organophosphatases |
| 04/22/2010 | US20100098692 Humanized Endoglin Antibodies |
| 04/22/2010 | US20100098689 4-1 bb ligand in inflammatory diseases |
| 04/22/2010 | US20100098686 Method for reducing levels of C-reactive protein |
| 04/22/2010 | US20100098683 MUC1 and Galectin-3 |
| 04/22/2010 | US20100098632 Hydroxyapatite particles |
| 04/22/2010 | US20100098625 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/22/2010 | CA2740561A1 Bsa-specific antibodies |
| 04/22/2010 | CA2740134A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 04/22/2010 | CA2739551A1 Dengue virus neutralizing antibodies and uses thereof |
| 04/22/2010 | CA2739429A1 Immunoglobulin variants and uses thereof |
| 04/22/2010 | CA2739302A1 Treatment method |
| 04/22/2010 | CA2737597A1 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177611A1 Method for measurement of concentration of antigen |
| 04/21/2010 | EP2177606A2 N-deoxyribosyltransferases from lactobacillus, corresponding nucleotide sequences and their applications |
| 04/21/2010 | EP2177537A2 Antibodies to MAdCAM |
| 04/21/2010 | EP2177536A1 Antibodies against amyloid-beta peptide |
| 04/21/2010 | EP2177535A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177231A2 Use of goat serum for veterinary treatment |
| 04/21/2010 | EP2176297A1 Antagonist antibodies of protease activated receptor-1 (par1) |
| 04/21/2010 | EP2176296A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 04/21/2010 | EP2176295A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 04/21/2010 | EP2176294A1 Mdl-1 uses |
| 04/21/2010 | EP2176292A1 Antibody purification process by precipitation |
| 04/21/2010 | EP2176291A1 Expression of full length igg and secretion into the culture medium of prokaryotic cells |
| 04/21/2010 | EP2175879A1 Treatment of prion protein related diseases |
| 04/21/2010 | EP1819728B1 Il-7 variants with reduced immunogenicity |
| 04/21/2010 | EP1689782B1 Anti-igfr1 antibody therapeutic combinations |
| 04/21/2010 | EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases |
| 04/21/2010 | EP1594960B1 Human cyclooxygenase-3 and uses thereof |
| 04/21/2010 | EP1519945B1 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 04/21/2010 | EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 04/21/2010 | CN101696242A Human anti rabies virus neutralizing antibody Fab as well as preparation method and application thereof |
| 04/21/2010 | CN101696234A Polypeptide for resisting rheumatoid arthritis and application thereof in pharmacy |
| 04/21/2010 | CN101695574A Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/21/2010 | CN101186647B Method for preparing chicken coccidiosis high immunity yolk antibody |
| 04/20/2010 | US7700827 Metal resistant plants and phytoremediation of environmental contamination |
| 04/20/2010 | US7700792 Highly active lysophosphatidic acid and method of screening therewith |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700743 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700740 Antibodies to CD83 |
| 04/20/2010 | US7700739 Complementary determining regions (CDR); interleukins (IL-12) |
| 04/20/2010 | US7700738 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 04/20/2010 | US7700737 heat shock proteins (Hsp70); metastatic neoplastic diseases, sarcomas, and carcinomas; humanizing, chimeric; monoclonal antibodies, hybridomas; inhibits natural killer cells |
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700735 High potency recombinant antibodies and method for producing them |
| 04/20/2010 | US7700726 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 04/20/2010 | US7700725 HIV antisense proteins |
| 04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700563 Synthetic heparin-binding factor analogs |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700547 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700316 CD109 nucleic acid molecules, polypeptides and methods of use |
| 04/20/2010 | US7700309 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau |
| 04/20/2010 | US7700303 Biosensors, method for obtaining the same and uses thereof |
| 04/20/2010 | US7700302 Method for generating and selecting antibodies against target protein |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |